<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="56980">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01858233</url>
  </required_header>
  <id_info>
    <org_study_id>IBEP</org_study_id>
    <nct_id>NCT01858233</nct_id>
  </id_info>
  <brief_title>The IBEP Study: an Intervention for Lifestyle Modification in Women With Gestational Diabetes</brief_title>
  <acronym>IBEP</acronym>
  <official_title>The IBEP Study: a Randomized Control Trial of an Educational Intervention for Lifestyle Modification in Women With Gestational Diabetes.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Pennsylvania</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Pennsylvania</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The IBEP study is a randomized control trial of a healthy lifestyle intervention program for
      women with gestational diabetes. The primary aim of the study is to evaluate whether women
      with gestational diabetes enrolled in an intensive behavioral educational program (IBEP)
      demonstrate lower mean fasting glucose levels measured by 2 hour 75 gram oral glucose
      tolerance test (OGTT) at 6 weeks postpartum compared to women with gestational diabetes who
      undergo routine gestational diabetes education and counseling.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>November 2012</start_date>
  <completion_date type="Anticipated">December 2014</completion_date>
  <primary_completion_date type="Anticipated">July 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Prevention</study_design>
  <primary_outcome>
    <measure>The IBEP Study</measure>
    <time_frame>2 years</time_frame>
    <safety_issue>No</safety_issue>
    <description>To evaluate mean fasting glucose levels measured by 2 hour 75 gram oral glucose tolerance test (OGTT) at 6 weeks in women enrolled in an intensive behavioral educational program compared to women with GDM who undergo routine GDM education and counseling.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>The IBEP Study</measure>
    <time_frame>2 years</time_frame>
    <safety_issue>No</safety_issue>
    <description>To evaluate the amount of weight lost in women enrolled in an intensive behavioral program and whether it correlates with more favorable lipid profiles at 6 weeks postpartum.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Gestational Diabetes</condition>
  <condition>Weight Gain During Pregnancy</condition>
  <condition>Weight Loss After Pregnancy</condition>
  <arm_group>
    <arm_group_label>Intensive Behavioral Modification</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>intensive dietary counseling, increased activity, lactation consult</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Routine care</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>standard dietary counseling</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Intensive Behavioral Modification</intervention_name>
    <description>Intensive dietary counseling, increased physical activity, lactation counseling</description>
    <arm_group_label>Intensive Behavioral Modification</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  women diagnosed with gestational diabetes between 20 and 34 weeks gestation

        Exclusion Criteria:

          -  women on chronic steroid therapy

          -  women with a diagnosis of GDM &lt;20 weeks or &gt;34 weeks
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Celeste P Durnwald, MD</last_name>
    <phone>215-662-6913</phone>
    <email>celeste.durnwald@uphs.upenn.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of Pennsylvania</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Celeste P Durnwald, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Kelly Allison, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2013</verification_date>
  <lastchanged_date>May 16, 2013</lastchanged_date>
  <firstreceived_date>May 8, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Gestational diabetes</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Weight Gain</mesh_term>
    <mesh_term>Weight Loss</mesh_term>
    <mesh_term>Diabetes, Gestational</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
